How are DBD strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the DBD strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 37.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,380.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a DBD strangle?

The breakeven for the DBD strangle priced on this page is roughly $66.20 and $103.80 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DBD market-implied 1-standard-deviation expected move is approximately 10.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current DBD implied volatility affect this strangle?

DBD ATM IV is at 37.90% with IV rank near 2.85%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

DBD Strangle Strategy

DBD (Diebold Nixdorf, Incorporated), in the Technology sector, (Software - Application industry), listed on NYSE.

Diebold Nixdorf, Incorporated focuses its efforts on modernizing global banking and retail interactions through comprehensive automation and digitalization. The company's operations are divided into two main areas: Banking and Retail. In the Banking segment, Diebold Nixdorf provides a wide range of hardware, including advanced cash recycling and dispensing units, intelligent deposit machines, tools for teller automation, kiosk technologies, and robust physical security infrastructure. These are supported by sophisticated software: customer-facing applications that streamline engagement, and powerful back-end platforms designed to manage channel transactions, oversee operations and integration, facilitate omnichannel experiences, monitor endpoints, remotely manage assets, execute customer marketing, handle merchandise, and conduct analytics. The company's banking services are extensive, encompassing proactive system monitoring and prompt incident resolution, delivered both remotely and via on-site visits. They also offer first and second-line maintenance, preventive care, on-demand support, and a suite of managed and outsourcing services for business processes, solution management, system upgrades, and transaction processing, alongside specialized cash management solutions.

DBD (Diebold Nixdorf, Incorporated) trades in the Technology sector, specifically Software - Application, with a market capitalization of approximately $2.94B, a trailing P/E of 27.64, a beta of 1.13 versus the broader market, a 52-week range of 53.93-89.05, average daily share volume of 446K, a public-listing history dating back to 2023, approximately 21K full-time employees. These structural characteristics shape how DBD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.13 places DBD roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on DBD?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current DBD snapshot

As of June 29, 2026, spot at $83.62, ATM IV 37.90%, IV rank 2.85%, expected move 10.87%. The strangle on DBD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 200-day expiry.

Why this strangle structure on DBD specifically: DBD IV at 37.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a DBD strangle, with a market-implied 1-standard-deviation move of approximately 10.87% (roughly $9.09 on the underlying). The 200-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DBD expiries trade a higher absolute premium for lower per-day decay. Position sizing on DBD should anchor to the underlying notional of $83.62 per share and to the trader's directional view on DBD stock.

DBD strangle setup

The DBD strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DBD near $83.62, the first option leg uses a $90.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DBD chain at a 200-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DBD shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$90.00	$7.15
Buy 1	Put	$80.00	$6.65

DBD strangle risk and reward

Net Premium / Debit: -$1,380.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$1,380.00
Breakeven(s): $66.20, $103.80
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

DBD strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on DBD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$6,619.00
$18.50	-77.9%	+$4,770.23
$36.99	-55.8%	+$2,921.45
$55.47	-33.7%	+$1,072.68
$73.96	-11.6%	-$776.10
$92.45	+10.6%	-$1,135.13
$110.94	+32.7%	+$713.64
$129.42	+54.8%	+$2,562.42
$147.91	+76.9%	+$4,411.19
$166.40	+99.0%	+$6,259.96

When traders use strangle on DBD

Strangles on DBD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the DBD chain.

DBD thesis for this strangle

The market-implied 1-standard-deviation range for DBD extends from approximately $74.53 on the downside to $92.71 on the upside. A DBD long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current DBD IV rank near 2.85% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DBD at 37.90%. As a Technology name, DBD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DBD-specific events.

DBD strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DBD positions also carry Technology sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DBD alongside the broader basket even when DBD-specific fundamentals are unchanged. Always rebuild the position from current DBD chain quotes before placing a trade.

Frequently asked questions

What is a strangle on DBD?: A strangle on DBD is the strangle strategy applied to DBD (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With DBD stock trading near $83.62, the strikes shown on this page are snapped to the nearest listed DBD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are DBD strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the DBD strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 37.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,380.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a DBD strangle?: The breakeven for the DBD strangle priced on this page is roughly $66.20 and $103.80 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DBD market-implied 1-standard-deviation expected move is approximately 10.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on DBD?: Strangles on DBD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the DBD chain.
How does current DBD implied volatility affect this strangle?: DBD ATM IV is at 37.90% with IV rank near 2.85%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.